지루피부염에서 Itraconazole의 치료 효과
Therapeutic Effect of Itraconazole in Seborrheic Dermatitis
2
조회
0
다운로드
0
인용
0
참고문헌
초록
Abstract
Background: Seborrheic dermatitis is a very common chronic inflammatory disease. The causal factor of the disease is still unknown, but early investigators focused on the role of Malassezia yeasts. These yeasts are also normal skin commensals, thus their importance as pathogens in this disorder came to be doubted. However, it was subsequently found that treatment of seborrheic dermatitis with an antifungal agent not only resulted in clinical improvement but also reduced the number of Malassezia yeasts on the skin. Object: The purpose of this study is to confirm relationship between seborrheric dermatits and Malassezia yeast, and to evaluate the therapeutic efficacy of oral itraconazole in the seborrheic dermatitis. Methods: Using the scrub-wash technique in the glabella and swabbing technique in the scalp, the number of cultured Malassezia yeasts were counted in 30 patients with seborrheic dermatitis and 20 control persons. The patients took itraconazole, 100mg/day, during 4weeks. The clinical and mycologic score were measured at the initial evaluation, followed after 2weeks and 4weeks Result: The number of Malassezia yeasts in patient with seborrheic dermatits were significantly higher than in normal control group. There was statistically significant decrease in the clinical and mycological score after a 4week trial of oral itraconazole in the seborrheic dermatitis group. Conclusion: This study indicates that Malassezia yeast may be one of the important causative factor of seborrheic dermatitis and itraconazole plays an important role in the treatment of seborrheic dermatitis.
참고문헌 (31)
- "Pityrosporum yeasts--What’s new", 40, pp.29~32 (1997)
- "International Commission on the Taxonomy of Fungi (ICTF): name changes in fungi of microbiological, industrial and medical importance", pp.285~287
- "김영표. 지루 피부염의 itraconazole의 치료. 대피지 1992", pp.81~86
- "Effective treatment of seborrheic dermatitis using a low dose, oral", 7, pp.59~67 (2002)
- "The genus Malassezia with description of for new species", 69, pp.337~355 (1996)
- "Seborrheic dermatitis is not causes by an altered immune response to Malassezia yeast", 139, pp.254~263 (1998)
- "Seborrheic dermatitis and Pityrosporum (Malassezia) folliculitis: characterization of inflammatory cells and mediators in the skin by immunohistochemistry.", 144, pp.549~556 (2001)
- "Malassezia and Trichosporon : two emerging pathogenic basidiomycetous yeast-like fungi", pp.1 367~378
- "Shuster S. The etiology of dandruff and mode of action of therapeutic agents. Br J Dermatol 1984", pp.235~242
- "et al. Double blind treatment of seborrheic dermatitis with 2%ketoconazole cream. J Am Acad Dermatol 1985", pp.852~856
- "Poyner T. The role of ketoconazole 2% shampoo in the treatment and prophylactic management of dandruff. J Dermatol Treat 1990", pp.177~179
- "Oral terbinafine for the treatment of seborrheic dermatitis in adults", 41, pp.821~822 (2002)
- "Collins-Lech C. Activation of complement by Pityrosporum", pp.93~97
- "Collins-Lech C. Analysis of the lymphocyte trnasformation response to pityrosporum orbiculare inpatients with tinea versicolor. Clin Exp Immunol 1982", pp.559~564
- "Scheynius A. An immunologic and cultural study of pityrosporumfolliculitis. J Am Acad Dermatol 1986", pp.429~433
- "Faergemann J. The role of P. ovale in seborrheic dermatitis. Seminars in Dermatology 1990", pp.262~268
- "et al. Seborrheic-like dermatitis of AIDS. J Am Acad Dermatol 1986", soepro(ff), pp.242~248
- "Faergement J. Quantitiative culture of P. ovale. Int J Dermaol 1984", pp.852~856
- "Faeregement J. The use of contact plate for quantitative cultures of pityrosporum ovale. Mykoson 1987", pp.298~304
- "A new and simple method for quantitative culture of P.ovale. Acta Derm Venereol 1988", pp.445~449
- "Kligman AM. A new method for the quantitative investigation of cutaneous bacteria. J Invest Dermatol 1965", pp.498~503
- "Holland KT. The distribution and ecology of Malassezia furfur and cutaneous bacteria on human skin. J Appl Bacteriol 1989", (tman fh), pp.47~52
- "지루피부염 병변에서 배양된 Malassezia 효모균의 분류.", 6, pp.70~76 (2001)
- "정상인 신체 부위에 따른 Malassezia 효모균의 균종별 분포.", 5, pp.120~128 (2000)
- "Antifungal agents: unapproved uses, dosages, or indications", 20, pp.481~489 (2002)
- "Determination of minimum inhibitory concentrations of several azole antifungal for Malassezia furfur", 8, pp.187~194 (1996)
- "Treatment of seborrheic dermatitis with antifungal drugs.", 173, pp.1026~1027 (1995)
- "Itraconazole : new horizons", 137, pp.1~7 (2002)
- "Itraconazole in the treatment of seborrheic dermatitis: a new treatment modality", 43, pp.63~66 (2004)
- "The use of itraconazole to treat cutaneous fungal infections children.", 199, pp.248~252 (1999)
- "AHFS 95 Drug information", pp.86~88 (1995)
